首页> 外文会议>World biomaterials congress >Drug delivery into multicellular tumor spheroids (MCTS) by polymeric micelles
【24h】

Drug delivery into multicellular tumor spheroids (MCTS) by polymeric micelles

机译:高分子胶束将药物递送到多细胞肿瘤球体(MCTS)中

获取原文

摘要

Introduction: Polymeric micelles have been used as promising nano drug carriers for cancer therapies. Two-dimensionally (2D) cultured tumor cells have been used as a standard model to study nanoparticle uptake and drug delivery in vitro. However, 2D cell models cannot represent all the features of real tumors and may lead to poor translation between the 2D monolayer in vitro results and in vivo tests. Multicellular tumor spheroid (MCTS) is considered as the first choice of 3D solid tumor models. Most MCTS exhibit higher similarity to in vivo tumor tissues than monolayer cells, and therefore have recently gained increasing recognition in biomedical research. More attempts have been made in using MCTS to investigate cellular responses to nano drug carriers for therapeutic applications. Interactions between nanoparticles and MCTS and the underlying mechanisms remain largely unknown. In this study, we investigated drug delivery efficiencies, anti-tumor and anti-metastasis activities of polymeric micelles with MCTS models. Materials and Methods: The multicellular tumor spheroids were prepared by culturing tumor cell lines with a hanging drop method or a liquid overlay method. Micelles were prepared by dialysis the block copolymers against water. Doxorubicin or Ruthenium-based anti-metastatic drug (RAPTA-C) was loaded into micelles. The MCTS were treated with micelles and the penetration, drug delivery, anti-tumor and anti-metastasis effects were investigated. Results and Discussion: HPMA-based polymeric micelles penetrated deeper and delivered more drug into MCTS than did free drug. The penetration of HPMA micelles depended more on transcellular transport than on diffusion through ECM between the cells. Stabilization via shell crosslinking improved the drug delivery efficiency of micelles in MCTS. RAPTA-C conjugated polymeric micelles showed improved anti-metastatic effects compared with free RAPTA-C for 2D cultured tumor cells. However, the anti-metastatic ability of RAPTA-C polymeric micelles exploited with MCTS showed contrary results to 2D cell culture models. Conclusion: Polymeric micelles improved the delivery of different drugs into MCTS compared with drugs in their free forms. However, the results with MCTS models were not inconsistent with those obtained from 2D cell models. Modifications to improve micellar delivery efficiency are highly desired to provide the greatest clinical benefit to cancer therapy. Introducing MCTS models into the evaluation of nanoparticles will be of great interest for the design of nano drug carriers.
机译:简介:高分子胶束已被用作有前途的纳米药物载体,用于癌症治疗。二维(2D)培养的肿瘤细胞已用作研究纳米颗粒体外吸收和药物递送的标准模型。但是,二维细胞模型不能代表真实肿瘤的所有特征,并且可能导致二维单层体外结果与体内测试之间的翻译不佳。多细胞肿瘤球体(MCTS)被认为是3D实体肿瘤模型的首选。与单层细胞相比,大多数MCTS与体内肿瘤组织的相似性更高,因此最近在生物医学研究中得到了越来越多的认可。在使用MCTS来研究细胞对纳米药物载体在治疗应用中的反应方面做出了更多尝试。纳米粒子和MCTS之间的相互作用以及潜在的机理在很大程度上仍然未知。在这项研究中,我们使用MCTS模型研究了聚合物胶束的给药效率,抗肿瘤和抗转移活性。材料与方法:通过悬滴法或液体覆盖法培养肿瘤细胞系来制备多细胞肿瘤球体。通过将嵌段共聚物用水透析来制备胶束。将阿霉素或基于钌的抗转移药(RAPTA-C)装入胶束中。用胶束处理MCTS,并研究其渗透性,药物递送,抗肿瘤和抗转移作用。结果与讨论:与游离药物相比,基于HPMA的聚合物胶束更深入地渗透到MCTS中,并释放出更多的药物。 HPMA胶束的渗透更多地取决于跨细胞运输,而不是取决于细胞之间通过ECM的扩散。通过壳交联的稳定性提高了MCTS中胶束的药物递送效率。与游离RAPTA-C相比,与2D培养的肿瘤细胞相比,与RAPTA-C共轭的聚合物胶束具有更高的抗转移效果。但是,MCTS开发的RAPTA-C聚合物胶束的抗转移能力显示了与2D细胞培养模型相反的结果。结论:与游离形式的药物相比,高分子胶束改善了不同药物向MCTS的递送。但是,MCTS模型的结果与从2D单元模型获得的结果并不矛盾。迫切需要改进胶束递送效率的修饰,以为癌症治疗提供最大的临床益处。将MCTS模型引入到纳米粒子的评估中将对纳米药物载体的设计非常感兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号